Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
China flag China · Delayed Price · Currency is CNY
22.26
+0.08 (0.36%)
Apr 30, 2026, 1:54 PM CST

SHA:688298 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,4503,0814,1656,5976,098
Short-Term Investments
----31.15
Trading Asset Securities
122.59207.581,0521,161168.07
Cash & Short-Term Investments
2,5723,2895,2177,7586,297
Cash Growth
-21.79%-36.95%-32.75%23.19%181.43%
Accounts Receivable
213.67230.17207.74309.361,184
Other Receivables
12.7919.1220.773.1353.96
Receivables
226.46249.28228.44382.491,238
Inventory
309.86308.96346.78431.92470.56
Other Current Assets
147.62131.45104.01175.42120.06
Total Current Assets
3,2563,9795,8968,7478,126
Property, Plant & Equipment
2,6452,7412,2611,074481.34
Long-Term Investments
47.8550.2752.3535.5925.45
Goodwill
----15.41
Other Intangible Assets
883.88690.91478.81481.24111.48
Long-Term Deferred Tax Assets
256.12268.47218.26193.2369.68
Long-Term Deferred Charges
42.1259.7161.0536.327.37
Other Long-Term Assets
8.13305.8528.05135.63139.81
Total Assets
7,1398,0958,99610,7048,977
Accounts Payable
481.4515.49600.491,5801,174
Accrued Expenses
65.2672.0368.45218.81175.55
Short-Term Debt
130.55116.78198.22--
Current Portion of Long-Term Debt
11.12300.2250.3--
Current Portion of Leases
-24.615.863.555.84
Current Income Taxes Payable
12.183.413.7717.67606.85
Current Unearned Revenue
37.5230.9934.77339.1471.19
Other Current Liabilities
93.82140.29113.93119.2425.4
Total Current Liabilities
831.861,2041,0862,2782,059
Long-Term Debt
158.99-30050-
Long-Term Leases
25.347.1743.9628.6512.65
Long-Term Unearned Revenue
26.0634.4810.7517.4617.01
Long-Term Deferred Tax Liabilities
0.040.230.042.76-
Other Long-Term Liabilities
11.0217.475.73.39-
Total Liabilities
1,0531,3031,4462,3812,088
Common Stock
201.6201.6201.6168120
Additional Paid-In Capital
397.89397.89395.42436.32549.21
Retained Earnings
5,6946,2686,7977,5306,201
Treasury Stock
-326.94-276.95---
Comprehensive Income & Other
26.1254.942.3728.27-12.72
Total Common Equity
5,9936,6457,4368,1636,857
Minority Interest
92.96146.34113.66160.1531.62
Shareholders' Equity
6,0866,7917,5508,3236,889
Total Liabilities & Equity
7,1398,0958,99610,7048,977
Total Debt
325.96488.76608.3382.218.49
Net Cash (Debt)
2,2462,8004,6097,6756,279
Net Cash Growth
-19.78%-39.24%-39.95%22.24%180.61%
Net Cash Per Share
11.6714.2422.8438.0831.14
Filing Date Shares Outstanding
190.02193.2201.6201.6201.6
Total Common Shares Outstanding
190.02193.2201.6201.6201.6
Working Capital
2,4242,7754,8106,4696,068
Book Value Per Share
31.5434.4036.8940.4934.01
Tangible Book Value
5,1095,9546,9577,6826,730
Tangible Book Value Per Share
26.8930.8234.5138.1033.38
Buildings
-1,4651,296586.6243.61
Machinery
-437.85360.52262.56177.03
Construction In Progress
-1,134796.48369.99112.45
Source: S&P Global Market Intelligence. Standard template. Financial Sources.